| Literature DB >> 15056006 |
John A McCauley1, Cory R Theberge, Joseph J Romano, Susan B Billings, Kenneth D Anderson, David A Claremon, Roger M Freidinger, Rodney A Bednar, Scott D Mosser, Stanley L Gaul, Thomas M Connolly, Cindra L Condra, Menghang Xia, Michael E Cunningham, Bohumil Bednar, Gary L Stump, Joseph J Lynch, Alison Macaulay, Keith A Wafford, Kenneth S Koblan, Nigel J Liverton.
Abstract
Two classes of 5-substituted benzimidazoles were identified as potent antagonists of the NR2B subtype of the N-methyl-d-aspartate (NMDA) receptor. Selected compounds show very good selectivity versus the NR2A, NR2C, and NR2D subtypes of the NMDA receptor as well as versus hERG-channel activity and alpha(1)-adrenergic binding. Benzimidazole 37a shows excellent activity in the carrageenan-induced mechanical hyperalgesia assay in rats as well as good pharmacokinetic behavior in dogs.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15056006 DOI: 10.1021/jm030483s
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446